Abstract
Hyperserotonemia is the most consistent serotonin-related finding in autism. The basis of this phenomenon, and its relationship to the central serotonergic dysfunction remains unclear. Platelet serotonin level (PSL) in 53 autistic adults and 45 healthy controls was measured. Mean PSL in autistic group (75.7 ± 37.4 ng/μL) was significantly higher than the control sample (59.2 ± 16.2 ng/μL) due to a presence of hyperserotonemic subjects which comprised 32% of the patients. PSL of autistic subjects did not correlate with the severity of symptoms, as measured by total CARS score, or the degree of mental retardation. However, significant negative relationship was observed between PSL and speech development, indicating the relationship between the peripheral 5HT concentrations and verbal abilities in autistic subjects.
Similar content being viewed by others
References
Anderson, G. M. (1987). Monoamines in autism: An update of neurochemical research on a pervasive developmental disorder. Medical Biology, 65, 67–74.
Campbell, M., Friedman, E., DeVito, E., Greenspan, L., & Collins, P. J. (1974). Blood serotonin in psychotic and brain damaged children. Journal of Autism and Childhood Schizophrenia, 4, 33–41.
Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., & Chugani, H. T. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45, 287–295.
Chugani, D. C., Muzik, O., Rothermel, R., Behen, M., Chakraborty, P., Mangner, T., et al. (1997). Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Annals of Neurology, 42, 666–669.
Cook, E. H. Jr., Arora, R. C., Anderson, G. M., Berry-Kravis, E. M., Yan, S. Y., Yeoh, H. C., et al. (1993). Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sciences, 52, 2005–2015.
Cook, E. H. Jr., & Leventhal, B. L. (1996). The serotonin system in autism. Current Opinion in Pediatrics, 8, 348–354.
Cook, E. H. Jr., Leventhal, B. L., Heller, W., Metz, J., Wainwright, M., & Freedman, D. X. (1990). Autistic children and their first-degree relatives: Relationships between serotonin and norepinephrine levels and intelligence. Journal of Neuropsychiatry and Clinical Neurosciences, 2, 268–274.
Coutinho, A. M., Oliveira, G., Morgadinho, T., Fesel, C., Macedo, T. R., Bento, C., et al. (2004). Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Molecular Psychiatry, 9, 264–271.
Croonenberghs, J., Delmeire, L., Verkerk, R., Lin, A. H., Meskal, A., Neels, H., et al. (2000). Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsychopharmacology, 22, 275–283.
Croonenberghs, J., Verkerk, R., Scharpe, S., Deboutte, D., & Maes, M. (2005). Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls. Life Sciences, 76, 2171–2183.
Cuccaro, M. L., Wright, H. H., Abramson, R. K., Marsteller, F. A., & Valentine, J. (1993). Whole-blood serotonin and cognitive functioning in autistic individuals and their first-degree relatives. Journal of Neuropsychiatry and Clinical Neurosciences, 5, 94–101.
Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman S., & Iyengar, R. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30, 582–589.
Janusonis, S. (2005). Serotonergic paradoxes of autism replicated in a simple mathematical model. Medical Hypotheses, 64, 742–750.
Jernej, B., Banovic, M., Cicin-Sain, L., Hranilovic, D., Balija, M., Oreskovic, D., & Folnegovic-Smalc, V. (2000). Physiological characteristics of platelet/circulatory serotonin: Study on a large human population. Psychiatry Research, 94, 153–162.
Jernej, B., Cicin-Sain, L., & Iskric, S. (1988). A simple and reliable method for monitoring platelet serotonin levels in rats. Life Sciences, 43, 1663–1670.
Jones, M. B., & Szatmari, P. (2002). A risk-factor model of epistatic interaction, focusing on autism. American Journal of Medical Genetics, 114, 558–565.
Kuperman, S., Beeghly, J., Burns, T., & Tsai, L. (1987). Association of serotonin concentration to behavior and IQ in autistic children. Journal of Autism and Developmental Disorders, 17, 133–140.
Limpert, E., Stahel, W. A., & Abbt, M. (2001). Log-normal ndistributions across the sciences: Keyes and clues. BioScience, 51, 341–352.
Marazziti, D., Muratori, F., Cesari, A., Masala, I., Baroni, S., Giannaccini, G., et al. (2000). Increased density of the platelet serotonin transporter in autism. Pharmacopsychiatry, 33, 165–168.
McBride, P. A., Anderson, G. M., Hertzig, M. E., Snow, M. E., Thompson, S. M., Khait, V. D., et al. (1998). Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 767–776.
McDougle, C. J., Naylor, S. T., Cohen D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996a). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001–1008.
McDougle, C .J., Naylor, S. T., Cohen, D. J., Aghajanian, G. K., Heninger, G. R., & Price, L. H. (1996b). Effects of tryptophan depletion in drug-free adults with autistic disorder. Archives of General Psychiatry, 53, 993–1000.
Muhle, R., Trentacoste, S. V., & Rapin, I. (2004). The genetics of autism. Pediatrics, 13, 472–486.
Mulder, E. J., Anderson, G. M., Kema, I. P., de Bildt, A., van Lang, N. D., den Boer, J. A., & Minderaa, R. B. (2004). Platelet serotonin levels in pervasive developmental disorders and mental retardation: Diagnostic group differences, within-group distribution, and behavioral correlates. Journal of the American Academy of Child and Adolescent Psychiatry 43, 491–499.
Owley, T., Leventhal, B. L., & Cook, E. H. (2003). Childhood Disorders: The autism spectrum disorders. In A. Tasman, J. Kay, & J. A. Lieberman (Eds.), Psychiatry. 2nd ed., (pp. 757–770). Chichester: Wiley.
Ritvo, E., Yuwiler, A., Geller, E., Plotkin, S., Mason, A., & Saeger, K. (1971). Maturational changes in blood serotonin levels and platelet counts. Biochemical Medicine 5, 90–96.
Schopler, E., Reichler, R. J., DeVellis, R. F., & Daly, K. (1980). Toward objective classification of childhood autism: Childhood autism rating scale (CARS). Journal of Autism and Developmental Disorders 10, 91–103.
Spivak, B., Golubchik, P., Mozes, T., Vered, Y., Nechmad, A., Weizman, A., & Strous, R. D. (2004). Low platelet-poor plasma levels of serotonin in adult autistic patients. Neuropsychobiology, 50, 157–160.
Whitaker-Azmitia, P. M. (2001). Serotonin and brain development: Role in human developmental diseases. Brain Research Bulletin, 56, 479–485.
Acknowledgments
This study was supported by the Ministry of Science Education and Sports of the Republic of Croatia. The authors wish to thank Mrs. Drina Bagaric, a medical laboratory engineer, for her skillful, kind, and gentle approach to the patients during blood sampling, and to Mrs. Katarina Karlo, a senior technician, for her assistance in PSL measurements.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hranilovic, D., Bujas-Petkovic, Z., Vragovic, R. et al. Hyperserotonemia in Adults with Autistic Disorder. J Autism Dev Disord 37, 1934–1940 (2007). https://doi.org/10.1007/s10803-006-0324-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-006-0324-6